PAPER Sharbafshaaer M, Siciliano M, Passaniti C, Sant'Elia V, Silvestro M, Russo A, Esposito S, Tedeschi G, Trojano L, Trojsi F

Screening of visuospatial abilities in amyotrophic lateral sclerosis (ALS): a pilot study using the battery for visuospatial abilities (BVA).

Orphanet J Rare Dis. 2025 Mar 8;20(1):110. PubMed.

PAPER Mesias A, Borges S, Pintado M, Baptista-Silva S

Bioactive peptides as multipotent molecules bespoke and designed for Alzheimer's disease.

Neuropeptides. 2025 Mar 4;111:102515. Epub 2025 Mar 4 PubMed.

PAPER Kahn OI, Dominguez SL, Glock C, Hayne M, Vito S, Sengupta Ghosh A, Adrian M, Burgess BL, Meilandt WJ, Friedman BA, Hoogenraad CC

Secreted neurofilament light chain after neuronal damage induces myeloid cell activation and neuroinflammation.

Cell Rep. 2025 Mar 7;44(3):115382. Epub 2025 Mar 7 PubMed.

PAPER Matveyenka M, Sholukh M, Kurouski D

Cytotoxicity of Amyloid β1-42 Fibrils to Brain Immune Cells.

ACS Chem Neurosci. 2025 Mar 8; Epub 2025 Mar 8 PubMed.

PAPER Giblin A, Cammack AJ, Blomberg N, Anoar S, Mikheenko A, Carcolé M, Atilano ML, Hull A, Shen D, Wei X, Coneys R, Zhou L, Mohammed Y, Olivier-Jimenez D, Wang LY, Kinghorn KJ, Niccoli T, Coyne AN, van der Kant R, Lashley T, Giera M, Partridge L, Isaacs AM

Author Correction: Neuronal polyunsaturated fatty acids are protective in ALS/FTD.

Nat Neurosci. 2025 Mar 7; Epub 2025 Mar 7 PubMed. Corrected paper.

PAPER

Novel mRNA isoforms in human microglia refine genetic associations with neurodegeneration.

Nat Genet. 2025 Mar 7; Epub 2025 Mar 7 PubMed.

PAPER Eide PK

Adult Hydrocephalus and the Glymphatic System.

Neurosurg Clin N Am. 2025 Apr;36(2):127-140. Epub 2025 Feb 5 PubMed.

PAPER Lu Q, Shao N, Fang Z, Ouyang Z, Shen Y, Yang R, Liu H, Cai B, Wei T

The anti-Alzheimer's disease effects of ganoderic acid A by inhibiting ferroptosis-lipid peroxidation via activation of the NRF2/SLC7A11/GPX4 signaling pathway.

Chem Biol Interact. 2025 Mar 5;412:111459. Epub 2025 Mar 5 PubMed.

PAPER Parhizkar S, Holtzman DM

The night's watch: Exploring how sleep protects against neurodegeneration.

Neuron. 2025 Feb 27; Epub 2025 Feb 27 PubMed.

PAPER Tserennadmid B, Nam MK, Park JH, Rhim H, Kang S

HAP/ClpP-mediated disaggregation and degradation of Mutant SOD1 aggregates: A potential therapeutic strategy for Amyotrophic lateral sclerosis (ALS).

Biochem Biophys Res Commun. 2025 Feb 28;756:151533. Epub 2025 Feb 28 PubMed.

PAPER T S S, N K

Taylor-dingo optimized RP-net for segmentation toward Alzheimer's disease detection and classification using deep learning.

Comput Biol Chem. 2025 Jun;116:108359. Epub 2025 Feb 13 PubMed.

PAPER Wu M, Zhang R, Fu P, Mei Y

Disrupted astrocyte-neuron signaling reshapes brain activity in epilepsy and Alzheimer's disease.

Neuroscience. 2025 Mar 27;570:132-151. Epub 2025 Feb 20 PubMed.

Leon French on Sex Differences in Blood of Alzheimer’s and Parkinson’s Patients

COMMENT I commend Grandke et al. for highlighting that their strongest pathway-level signal, "SRP-dependent cotranslational protein targeting to membrane," aligns with the gingipain hypothesis. This pathway primarily comprises ribosomal proteins, e.g. R

PAPER Avey DR, Ng B, Vialle RA, Kearns NA, Lopes Kd, Iatrou A, Tissera SD, Vyas H, Saunders DM, Flood DJ, Xu J, Tasaki S, Gaiteri C, Bennett DA, Wang Y

Uncovering Plaque-Glia Niches in Human Alzheimer's Disease Brains Using Spatial Transcriptomics

bioRxiv2024.09.05.611566 .

PSEN1 Q223K

MUTATIONS PSEN1 73659470 GRCh37/hg19 rs1898776259 C A 73192762 GRCh38/hg38 rs1898776259 C A Exon 7 Coding Increased Aβ42 levels and the Aβ42/Aβ40 ratio in cells. Unknown. Q223K Alzheimer's Disease: Not ClassifiedAlzheimer's Disease Detailed information on